Health Clinical Trial - Characteristics of Intestinal Bacteria & Their

Status Recruiting

Clinical Trial Summary

Microbes and the human body maintain a complex relationship of interaction and influence. Different regions, altitudes, and dietary habits have different degrees of influence on the composition of children's intestinal flora. Therefore, the development and maturation process of children's intestinal flora in plateau areas was discovered, and its relationship with children's immunity, metabolism, and growth was understood. The mechanism of action of children's intestinal flora on immunity, growth and development was further analyzed by comparing it with people in low-altitude areas, to provide a scientific basis for improving children's health in plateau areas.

Clinical Trial Description

This observational study aims to gain a deeper understanding of the interactions and influence of microbes on the human body. By comparing the gut microbiota composition of children in different regions, at varying altitudes, and with distinct dietary habits, the study aims to answer two key questions: What are the characteristics of children's gut microbiota in different regions, at different altitudes, and with different dietary habits? What is the relationship between the development and maturation process of children's gut microbiota in plateau areas and their immunity, metabolism, and growth? Participants will be asked to provide fecal samples for analysis during the study. They may also be asked to answer questionnaires about their lifestyle factors such as diet and physical activity. The comparison group is included, researchers will compare the gut microbiota composition and diversity of children in low-altitude areas with those in plateau areas to assess any differences in their gut microbiota profiles. By comparing these differences, the mechanism of action of children's gut microbiota on immunity, growth and development can be further analyzed. The findings of this study aim to provide a scientific basis for improving children's health in plateau areas. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06157346
Study type	Observational [Patient Registry]
Source	Ruijin Hospital
Contact	Xinqiong Wang
Phone	0086-021-64370045
Email	wxq11671@rjh.com.cn
Status	Recruiting
Phase
Start date	October 16, 2023
Completion date	August 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03781817` - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures	Phase 4
Recruiting	`NCT05424757` - Polyethylene Glycol Safety in Children
Recruiting	`NCT04602429` - Children's Acute Surgical Abdomen Programme
Completed	`NCT04933734` - Turkish Cultural Adaptation, Validity and Reliability of the "Physical Activity-Specific Rumination Scale for Children"
Completed	`NCT03457688` - Effect of Prebiotic Fructans to Reduce Number of Febrile Infections in Children	N/A
Recruiting	`NCT05113420` - The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
Completed	`NCT03241355` - Prebiotic Fructans on the Incidence of Acute Infectious Diseases in Children	N/A
Not yet recruiting	`NCT05484102` - Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children	N/A
Recruiting	`NCT04460313` - Nasopharyngeal Carriage of S. Pneumoniae	N/A
Not yet recruiting	`NCT05974917` - Serious gaMes as Emerging E-health Interventions for Young People With neurologicaL or rEspiratory disoRders
Completed	`NCT04057612` - Correlation Between Core Temperature and Skin Temperature in Pediatrics
Completed	`NCT04256590` - Tongue Depressor-related Tongue Swelling
Recruiting	`NCT03319927` - Reducing Pesticide Exposures in Child Care Centers	N/A
Enrolling by invitation	`NCT05513235` - Feasibility Study of a Mobile Digital Personal Health Record for Family-Centered Care Coordination for Children and Youth With Special Healthcare Needs	N/A
Completed	`NCT04615000` - SeroCovid<19: Covid-19 Seroconversion in Tertiary Pediatric Patients
Not yet recruiting	`NCT05568849` - Optical Coherence Tomography Angiography (OCTA) in Children's Cardiac Surgery	N/A
Recruiting	`NCT04206956` - Anxiety and Chronic Postsurgical Pain Following Ambulatory Surgery in Children
Completed	`NCT04315220` - Corestability Training in Overweight Children	N/A
Recruiting	`NCT05043870` - Combined Immunosuppression for Pediatric Crohn's Disease	Phase 4
Not yet recruiting	`NCT05511194` - Safety and Efficacy of ERAS Therapeutic Protocol for Complicated Appendicitis in Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms